BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15870859)

  • 21. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours.
    Rofstad EK; Måseide K
    Int J Radiat Biol; 1999 Nov; 75(11):1377-93. PubMed ID: 10597912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
    Le Calvé B; Rynkowski M; Le Mercier M; Bruyère C; Lonez C; Gras T; Haibe-Kains B; Bontempi G; Decaestecker C; Ruysschaert JM; Kiss R; Lefranc F
    Neoplasia; 2010 Sep; 12(9):727-39. PubMed ID: 20824049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation.
    Lin Z; Weinberg JM; Malhotra R; Merritt SE; Holzman LB; Brosius FC
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E958-66. PubMed ID: 10780954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia.
    Meier V; Guscetti F; Roos M; Ohlerth S; Pruschy M; Rohrer Bley C
    PLoS One; 2016; 11(2):e0149993. PubMed ID: 26906567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between primary chemo- and radiation sensitivity in a panel of highly malignant human soft tissue sarcoma xenografts.
    Budach W; Budach V; Dinges S; Stuschke M; Sack H
    Radiother Oncol; 1997 Feb; 42(2):181-7. PubMed ID: 9106928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
    Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
    Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
    J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.
    Tuomela J; Grönroos TJ; Valta MP; Sandholm J; Schrey A; Seppänen J; Marjamäki P; Forsback S; Kinnunen I; Solin O; Minn H; Härkönen PL
    BMC Cancer; 2010 Oct; 10():596. PubMed ID: 21034500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
    Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No detectable hypoxia in malignant salivary gland tumors: preliminary results.
    Wijffels KI; Hoogsteen IJ; Lok J; Rijken PF; Marres HA; de Wilde PC; van der Kogel AJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1319-25. PubMed ID: 18973979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.
    Cantuaria G; Fagotti A; Ferrandina G; Magalhaes A; Nadji M; Angioli R; Penalver M; Mancuso S; Scambia G
    Cancer; 2001 Sep; 92(5):1144-50. PubMed ID: 11571727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose transporter 1 expression in canine osteosarcoma.
    Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
    Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.
    Airley R; Evans A; Mobasheri A; Hewitt SM
    Ann Anat; 2010 May; 192(3):133-8. PubMed ID: 20395120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
    Busk M; Mortensen LS; Nordsmark M; Overgaard J; Jakobsen S; Hansen KV; Theil J; Kallehauge JF; D'Andrea FP; Steiniche T; Horsman MR
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):186-97. PubMed ID: 23076620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
    Mayer A; Höckel M; Wree A; Vaupel P
    Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.
    Fiebig HH; Maier A; Burger AM
    Eur J Cancer; 2004 Apr; 40(6):802-20. PubMed ID: 15120036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis.
    Williams KJ; Telfer BA; Airley RE; Peters HP; Sheridan MR; van der Kogel AJ; Harris AL; Stratford IJ
    Oncogene; 2002 Jan; 21(2):282-90. PubMed ID: 11803471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.
    Kostourou V; Troy H; Murray JF; Cullis ER; Whitley GS; Griffiths JR; Robinson SP
    Neoplasia; 2004; 6(4):401-11. PubMed ID: 15256062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of glucose transport proteins for tumor imaging: is it feasible?
    Nelson CA; Wang QJ; Bourque JP; Crane PD
    J Nucl Med; 1996 Jun; 37(6):1031-7. PubMed ID: 8683296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.